A recent article in JAMA Oncology (2018;4:1323-1324) highlighted a perceived variability between several guidelines for the management of chronic pain from the CDC, National Comprehensive Cancer Network (NCCN) and American Society of Clinical Oncology (ASCO). Now, a comparative analysis published in the Journal of the National Comprehensive Cancer Network (JNCCN 2020:18[4]):392-399) focuses on bridging the gap among clinical practice guidelines for pain management in cancer and sickle cell
JULY 30, 2020